OPRX (OptimizeRx) ROIC %: 0.88% (As of Mar. 2026)


OPRX OptimizeRx Corp OPRX
54 GF Score
Price $5.72
GF Value $12.98
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is OptimizeRx ROIC %?

OptimizeRx OPRX +5.54% 54 ROIC % is 0.88% as of Mar. 2026. GuruFocus rates OPRX with a GF Score™ of 54/100 and a GF Value™ of $12.98 (Significantly Undervalued). The stock has 3 warning signs investors should review.

ROIC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROC %. OptimizeRx's annualized return on invested capital (ROIC %) for the quarter that ended in Mar. 2026 was 0.88%.

As of today (2026-06-30), OptimizeRx's WACC % is 12.27%. OptimizeRx's ROIC % is 7.58% (calculated using TTM income statement data). OptimizeRx earns returns that do not match up to its cost of capital. It will destroy value as it grows.


OptimizeRx  (NAS:OPRX) ROIC % Explanation

ROIC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROC %. The reason book values of debt and equity are used is because the book values are the capital the company received when issuing the debt or receiving the equity investments.

There are four key components to this definition. The first is the use of operating income or EBIT rather than net income in the numerator. The second is the tax adjustment to this operating income or EBIT, computed as a hypothetical tax based on an effective or marginal tax rate. The third is the use of book values for invested capital, rather than market values. The final is the timing difference; the capital invested is from the end of the prior year whereas the operating income or EBIT is the current year's number.

Why is ROIC % important?

Because it costs money to raise capital. A firm that generates higher returns on investment than it costs the company to raise the capital needed for that investment is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases, whereas a firm that earns returns that do not match up to its cost of capital will destroy value as it grows.

As of today, OptimizeRx's WACC % is 12.27%. OptimizeRx's ROIC % is 7.58% (calculated using TTM income statement data). OptimizeRx earns returns that do not match up to its cost of capital. It will destroy value as it grows.


Be Aware

Like ROE % and ROA %, ROIC % is calculated with only 12 months of data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.


OptimizeRx ROIC % Related Terms


OptimizeRx ROIC % Historical Data

* Premium members only.

The historical data trend for OptimizeRx's ROIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OptimizeRx ROIC % Chart

OptimizeRx Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROIC %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.81 -24.39 -11.85 -4.20 6.38

OptimizeRx Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROIC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -4.06 8.38 4.48 17.57 0.88

OPRX vs CCLD, DH, HCAT: ROIC % Comparison

For the Health Information Services subindustry, OptimizeRx's ROIC %, along with its competitors' market caps and ROIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


OptimizeRx ROIC % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, OptimizeRx's ROIC % distribution charts can be found below:

* The bar in red indicates where OptimizeRx's ROIC % falls into.


OPRX
54GF Score
OptimizeRx Corp OPRX
ROIC % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

OptimizeRx ROIC % Calculation

OptimizeRx's annualized Return on Invested Capital (ROIC %) for the fiscal year that ended in Dec. 2025 is calculated as:

ROIC % (A: Dec. 2025 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (A: Dec. 2024 ) + Invested Capital (A: Dec. 2025 ))/ count )
=12.061 * ( 1 - 26.16% )/( (141.775 + 137.24)/ 2 )
=8.9058424/139.5075
=6.38 %

where

OptimizeRx's annualized Return on Invested Capital (ROIC %) for the quarter that ended in Mar. 2026 is calculated as:

ROIC % (Q: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2025 ) + Invested Capital (Q: Mar. 2026 ))/ count )
=1.584 * ( 1 - 23.14% )/( (137.24 + 139.482)/ 2 )
=1.2174624/138.361
=0.88 %

where

Note: The Operating Income data used here is four times the quarterly (Mar. 2026) data. The tax rate is limited to between 0% and 100%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROIC % →
What does a ROIC % of 0.88% mean?
OptimizeRx (OPRX) has a ROIC % of 0.88% as of Mar. 2026. Return on invested capital is the ratio of current-period net income to average two-period invested capital. View historical data on OptimizeRx and its competitors.
Is OptimizeRx's ROIC % too high?
OptimizeRx's current ROIC % is 0.88%. The Healthcare Providers & Services industry median ROIC % is 3.08. OptimizeRx's value of 0.88% is 71.4% below this industry median. Overall, OptimizeRx has a GF Score™ of 54/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does OptimizeRx's ROIC % compare to CCLD and DH?
OptimizeRx's ROIC % of 0.88% can be compared against companies in the Healthcare Providers & Services industry. The industry median ROIC % is 3.08. OptimizeRx's value of 0.88% is 71.4% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROIC % for a Healthcare Providers & Services company?
The median ROIC % among Healthcare Providers & Services companies is 3.08, based on 668 companies in the industry. Companies in the top quartile (top 25%) have a ROIC % significantly above this median, while those in the bottom quartile fall well below. However, ROIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. OptimizeRx's current ROIC % of 0.88% is 71.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROIC % mean?
A high ROIC % can signal that a stock is expensive relative to its fundamentals. Return on invested capital is the ratio of current-period net income to average two-period invested capital. View historical data on OptimizeRx and its competitors. For the Healthcare Providers & Services industry, the median ROIC % is 3.08 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. OptimizeRx's current ROIC % is 0.88%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OptimizeRx stock overvalued right now?
Based on GuruFocus' analysis, OptimizeRx (OPRX) is currently considered Significantly Undervalued. The stock's GF Value™ is $12.98, compared to a current price of $5.72 — trading 55.9% below its estimated fair value. The current ROIC % is 0.88% and 71.4% below the Healthcare Providers & Services industry median of 3.08. OptimizeRx's overall GF Score™ is 54/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROIC % calculated?
ROIC % is calculated from a company's financial statements. For OptimizeRx (OPRX), the current ROIC % is 0.88% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is OptimizeRx (OPRX) Overvalued in 2026?

Based on GuruFocus' analysis, OptimizeRx stock appears to be undervalued. The current stock price of $5.72 is trading 55.9% below its estimated GF Value™ of $12.98. GuruFocus considers OptimizeRx to be Significantly Undervalued.

Key valuation signals for OPRX:

  • ROIC %: 0.88%
  • GF Value™: $12.98 vs. price of $5.72 (55.9% below fair value)
  • GF Score™: 54/100 with 3 warning signs
  • Industry Position: 71.4% below the Healthcare Providers & Services median

No single metric tells the full story. See the OPRX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


OptimizeRx Business Description

Address 260 Charles Street, Suite 302, Waltham, MA, USA, 02453
OptimizeRx Corp is engaged in the healthcare market in the United States. is a digital healthcare technology company that connects over two million HCPs and millions of their patients through an intelligent technology platform embedded within a proprietary omnichannel network. OptimizeRx helps life sciences organizations engage and support their customers through its combined HCP and DTC marketing strategies.
54GF Score

Get the complete analysis for OPRX

ROIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$5.72
Price
$12.98
GF Value